




Searching News Database: InterMune
HSMN NewsFeed - 7 Nov 2019
Neurana Pharmaceuticals Appoints Randall Kaye, M.D., Chief Medical Officer
Neurana Pharmaceuticals Appoints Randall Kaye, M.D., Chief Medical Officer
HSMN NewsFeed - 28 Jan 2019
Indalo Therapeutics Appoints Seasoned Biopharmaceutical Executive Robert Jacks President & CEO
Indalo Therapeutics Appoints Seasoned Biopharmaceutical Executive Robert Jacks President & CEO
HSMN NewsFeed - 4 Apr 2018
Angus Russell to Succeed Melvin Booth as Mallinckrodt Chairman of the Board in May 2018
Angus Russell to Succeed Melvin Booth as Mallinckrodt Chairman of the Board in May 2018
HSMN NewsFeed - 7 Mar 2016
Anthera Pharmaceuticals Announces Appointment of Dr. James Pennington as Interim Chief Medical Officer
Anthera Pharmaceuticals Announces Appointment of Dr. James Pennington as Interim Chief Medical Officer
HSMN NewsFeed - 30 Nov 2015
OticPharma Appoints Keith A. Katkin as Chairman of the Board of Directors
OticPharma Appoints Keith A. Katkin as Chairman of the Board of Directors
HSMN NewsFeed - 4 Jun 2015
Ultragenyx Appoints Dennis Huang as Chief Technical Operations Officer and Senior Vice President
Ultragenyx Appoints Dennis Huang as Chief Technical Operations Officer and Senior Vice President
HSMN NewsFeed - 14 Apr 2015
Eiger BioPharmaceuticals Announces Senior Staff Appointments in Clinical Development and Regulatory Affairs
Eiger BioPharmaceuticals Announces Senior Staff Appointments in Clinical Development and Regulatory Affairs
HSMN NewsFeed - 27 Mar 2014
Oculus Innovative Sciences Announces Appointment of Sharon Barbari to Its Board of Directors
Oculus Innovative Sciences Announces Appointment of Sharon Barbari to Its Board of Directors
HSMN NewsFeed - 25 Feb 2014
InterMune Reports Phase 3 ASCEND Trial Results of Pirfenidone in Idiopathic Pulmonary Fibrosis (IPF)
InterMune Reports Phase 3 ASCEND Trial Results of Pirfenidone in Idiopathic Pulmonary Fibrosis (IPF)
HSMN NewsFeed - 16 Oct 2013
Newly Established Medac Pharma, Inc. Appoints Industry Veteran Terri Shoemaker as President and CEO
Newly Established Medac Pharma, Inc. Appoints Industry Veteran Terri Shoemaker as President and CEO
HSMN NewsFeed - 5 Jun 2012
Former Pfizer Worldwide Business Development Director Joins Australian Drug Development Company Agenix
Former Pfizer Worldwide Business Development Director Joins Australian Drug Development Company Agenix
HSMN NewsFeed - 27 Mar 2012
InterMune Appoints Mr. Jean-Jacques Bienaime and Dr. Frank Verwiel to Board of Directors
InterMune Appoints Mr. Jean-Jacques Bienaime and Dr. Frank Verwiel to Board of Directors
HSMN NewsFeed - 17 Feb 2011
AVANIR Pharmaceuticals Appoints Gregory J. Flesher to Senior Vice President and Chief Business Officer
AVANIR Pharmaceuticals Appoints Gregory J. Flesher to Senior Vice President and Chief Business Officer
HSMN NewsFeed - 17 Dec 2010
InterMune Announces Senior Leadership Appointments to Prepare for Launch of Esbriet (Pirfenidone) in Europe
InterMune Announces Senior Leadership Appointments to Prepare for Launch of Esbriet (Pirfenidone) in Europe
HSMN NewsFeed - 17 Dec 2010
InterMune Announces Positive Opinion for Approval of Esbriet (Pirfenidone) in European Union
InterMune Announces Positive Opinion for Approval of Esbriet (Pirfenidone) in European Union
HSMN NewsFeed - 2 Mar 2010
InterMune Announces Submission of MAA for Pirfenidone for the Treatment of Patients With IPF
InterMune Announces Submission of MAA for Pirfenidone for the Treatment of Patients With IPF
HSMN NewsFeed - 17 Dec 2009
Medivation Announces Organizational Changes to Support Anticipated Growth and Future Commercialization
Medivation Announces Organizational Changes to Support Anticipated Growth and Future Commercialization
HSMN NewsFeed - 5 Nov 2009
InterMune Announces Appointments of Senior Leadership to Prepare for Potential Launch of Pirfenidone
InterMune Announces Appointments of Senior Leadership to Prepare for Potential Launch of Pirfenidone
HSMN NewsFeed - 19 May 2008
InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA
InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA
HSMN NewsFeed - 15 May 2008
Proteolix Appoints Thomas Kassberg Executive Vice President of Corporate Development
Proteolix Appoints Thomas Kassberg Executive Vice President of Corporate Development
HSMN NewsFeed - 18 Mar 2008
Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct
Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct
HSMN NewsFeed - 3 Mar 2008
Pfizer Names William Ringo Senior Vice President of Strategy and Business Development
Pfizer Names William Ringo Senior Vice President of Strategy and Business Development
HSMN NewsFeed - 4 Jan 2008
Trellis Bioscience Appoints John Wulf as EVP, Business Operations and Chief Business Officer
Trellis Bioscience Appoints John Wulf as EVP, Business Operations and Chief Business Officer
HSMN NewsFeed - 30 Aug 2007
Hana Biosciences Appoints S. Michael Imperiale, Jr., M.D., as Vice President, Clinical Research Operations
Hana Biosciences Appoints S. Michael Imperiale, Jr., M.D., as Vice President, Clinical Research Operations
HSMN NewsFeed - 5 Jul 2007
Aradigm Corporation Names Norman Halleen as Interim Chief Financial Officer
Aradigm Corporation Names Norman Halleen as Interim Chief Financial Officer
HSMN NewsFeed - 23 Apr 2007
DiObex Announces the Appointment of David Cory as Chief Executive Officer
DiObex Announces the Appointment of David Cory as Chief Executive Officer
HSMN NewsFeed - 5 Mar 2007
InterMune Discontinues Phase 3 INSPIRE Trial of Actimmune in Idiopathic Pulmonary Fibrosis
InterMune Discontinues Phase 3 INSPIRE Trial of Actimmune in Idiopathic Pulmonary Fibrosis
HSMN NewsFeed - 25 Jan 2007
James Shaffer Joins New River Pharmaceuticals as Vice President, Sales and Marketing
James Shaffer Joins New River Pharmaceuticals as Vice President, Sales and Marketing
HSMN NewsFeed - 18 Dec 2006
Aerovance Adds Accomplished Product Commercialization Executive to Leadership Team
Aerovance Adds Accomplished Product Commercialization Executive to Leadership Team
HSMN NewsFeed - 16 Oct 2006
Zogenix Appoints J.D. Haldeman Vice President, Commercial Strategy & Corporate Communications
Zogenix Appoints J.D. Haldeman Vice President, Commercial Strategy & Corporate Communications
HSMN NewsFeed - 13 Sep 2006
Anthera Pharmaceuticals Secures $36M Venture Financing to Initiate Clinical Programs
Anthera Pharmaceuticals Secures $36M Venture Financing to Initiate Clinical Programs
HSMN NewsFeed - 8 May 2006
Athenagen Announces the Appointment of John Donovan as Chief Financial Officer
Athenagen Announces the Appointment of John Donovan as Chief Financial Officer
HSMN NewsFeed - 27 Apr 2006
InterMune Initiates Phase III Program Evaluating Pirfenidone in Patients With IPF
InterMune Initiates Phase III Program Evaluating Pirfenidone in Patients With IPF
HSMN NewsFeed - 11 Jan 2006
AVANIR Pharmaceuticals Hires Randall E. Kaye, M.D. as Vice President of Medical Affairs
AVANIR Pharmaceuticals Hires Randall E. Kaye, M.D. as Vice President of Medical Affairs
HSMN NewsFeed - 3 Jan 2006
InterMune Completes Divestiture of Infergen(R) for up to $135.5 Million in Cash
InterMune Completes Divestiture of Infergen(R) for up to $135.5 Million in Cash
HSMN NewsFeed - 3 Jan 2006
Valeant Pharmaceuticals Completes Acquisition of Hep-C Drug Infergen(R) From InterMune
Valeant Pharmaceuticals Completes Acquisition of Hep-C Drug Infergen(R) From InterMune
Additional items found! 63

Members Archive contains
63 additional stories matching:
InterMune
(Password required)
InterMune
(Password required)